TY - JOUR
T1 - Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)
AU - Reiberger, Thomas
AU - Püspök, Andreas
AU - Schoder, Maria
AU - Baumann-Durchschein, Franziska
AU - Bucsics, Theresa
AU - Datz, Christian
AU - Dolak, Werner
AU - Ferlitsch, Arnulf
AU - Finkenstedt, Armin
AU - Graziadei, Ivo
AU - Hametner, Stephanie
AU - Karnel, Franz
AU - Krones, Elisabeth
AU - Maieron, Andreas
AU - Mandorfer, Mattias
AU - Peck-Radosavljevic, Markus
AU - Rainer, Florian
AU - Schwabl, Philipp
AU - Stadlbauer, Vanessa
AU - Stauber, Rudolf
AU - Tilg, Herbert
AU - Trauner, Michael
AU - Zoller, Heinz
AU - Schöfl, Rainer
AU - Fickert, Peter
N1 - Publisher Copyright:
© 2017, The Author(s).
PY - 2017/11/1
Y1 - 2017/11/1
N2 - The Billroth III guidelines were developed during a consensus meeting of the Austrian Society of Gastroenterology and Hepatology (ÖGGH) and the Austrian Society of Interventional Radiology (ÖGIR) held on 18 February 2017 in Vienna. Based on international guidelines and considering recent landmark studies, the Billroth III recommendations aim to help physicians in guiding diagnostic and therapeutic strategies in patients with portal hypertension.
AB - The Billroth III guidelines were developed during a consensus meeting of the Austrian Society of Gastroenterology and Hepatology (ÖGGH) and the Austrian Society of Interventional Radiology (ÖGIR) held on 18 February 2017 in Vienna. Based on international guidelines and considering recent landmark studies, the Billroth III recommendations aim to help physicians in guiding diagnostic and therapeutic strategies in patients with portal hypertension.
KW - Austria
KW - Carbazoles/therapeutic use
KW - Carvedilol
KW - Comorbidity
KW - Early Medical Intervention
KW - Esophageal and Gastric Varices/prevention & control
KW - Gastrointestinal Hemorrhage/prevention & control
KW - Humans
KW - Hypertension, Portal/diagnosis
KW - Liver Cirrhosis/diagnosis
KW - Mass Screening
KW - Propanolamines/therapeutic use
KW - Propranolol/therapeutic use
KW - Randomized Controlled Trials as Topic
KW - Timolol/therapeutic use
UR - http://www.scopus.com/inward/record.url?scp=85031917456&partnerID=8YFLogxK
U2 - 10.1007/s00508-017-1262-3
DO - 10.1007/s00508-017-1262-3
M3 - Journal article
C2 - 29063233
SN - 0043-5325
VL - 129
SP - 135
EP - 158
JO - Wiener Klinische Wochenschrift
JF - Wiener Klinische Wochenschrift
IS - Suppl 3
ER -